Compare TROW & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TROW | STE |
|---|---|---|
| Founded | 1937 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 24.5B |
| IPO Year | N/A | 1992 |
| Metric | TROW | STE |
|---|---|---|
| Price | $105.69 | $259.24 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $105.82 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 1.6M | 429.9K |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.81% | 0.97% |
| EPS Growth | 0.40 | ★ 59.39 |
| EPS | ★ 9.17 | 6.97 |
| Revenue | ★ $7,205,200,000.00 | $5,702,415,000.00 |
| Revenue This Year | $5.62 | $9.61 |
| Revenue Next Year | $5.82 | $6.23 |
| P/E Ratio | ★ $11.52 | $37.18 |
| Revenue Growth | 4.25 | ★ 7.08 |
| 52 Week Low | $77.85 | $204.90 |
| 52 Week High | $118.32 | $269.44 |
| Indicator | TROW | STE |
|---|---|---|
| Relative Strength Index (RSI) | 51.17 | 50.01 |
| Support Level | $103.43 | $257.86 |
| Resistance Level | $108.17 | $269.44 |
| Average True Range (ATR) | 2.65 | 6.24 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 46.69 | 49.93 |
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of September, the firm had $1.767 trillion in managed assets, composed of equity (50%), balanced (35%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.